Tiziana Life Sciences is trading at $1.04 (7.5%) up in after-hours trading, extending its recent recovery following the selloff on July 24.

  • The upward move appears to reflect ongoing stock-specific dip buying and a broader risk-on sentiment rather than a new catalyst.
  • There are no fresh company-specific headlines, earnings releases, or regulatory updates linked to the July 28 price action.